CVS - Zatchot Flashcards

1
Q

explain Heart failure , DF,Classification , Clinical manifestation

A

—Df: its progressive clinical syndrome in which either structural or functional abnormalities impair the ability of the heart to meet the metabolic demands of the body
—Classification: they are 2
1-Anatomical:
1.1 Anatomical left-sided : usually duo to systemic hypertension
1.2 Anatomical right-sided : caused by to many things such as pre load , left-sided HF cause Pulmonary Conjation which lead to fail of the right side
1.3 in both sided
2-Pathophysiological :
2.1 systolic : ventricle cant pump the blood through systolic phase which is bcs the muscle are week Ex> ischemic heart disease
2.2 diastolic : duo to hypertrophy the heart cant pump the required amount if the blood in the filing phase
—Clinical manifestation:
decrease Cop leads to following mechanism:
1-sympathetic over activity duo to decreased oxygen to brain leading tachycardia
2-renal ischemia : increase of RAAS ( renin angiotensin aldosterone system) lead to V.C and aldosterone lead to salt and water retention which lead to increase after load and preload and more heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

explain the drug therapy of HF

A

1-Positive Iontropic
- Cardiac glycosides > digoxin
- Debutamine ( for short term only )
- phosphodiestrase inhibitor > Milrinone
2-ACE inhibitors
3-V.D
4-B.Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

explain the Glycosides Drugs , chemical structure , molecular mechanism,Autonomic effect , pharmacological effect , uses , Contraindications,

A

—Drugs :
1-Digoxin Tab
2-Strophanthin K Amp
-Chemical structure: it consists of :
1-Steroid nucleus : lipophilic and essential for activity
2-Lacton ring : hydrophilic and essential for activity
3-Series of sugar : linked to C 3 of steroid and isn’t essential for activity , changing in the glucose would lead to changes in the pharmacokinetics
—molecular mechanism:
its inhibit Na+K+ atapse enzyme , Entering of the sodium to the cell is Passive action so we dont need The
Na+/K+atapes pump so accumulation of the Sodium inside the cell and K+ extracellular, Accumulation of intercellular Sodium leads to :
1-increase the Calcium release from the Sarcoplasmic reticulum
2-Displacement of intercellular Calcium from binding site
3-increases intercellular Sodium prevent Calcium explosions from the cell by inhibition of Na+/Ca+ exchanger
—Autonomic effect :
1-increase Vegal activity > bradycardia
2-decrease sympathetic activity duo to better Oxygenation
—Pharmacological effect :
1-increase Contractility duo to accumulation of Calcium
2-decrease RAAS secretion
3-relief of lung conjation
4-decrease HR duo to vegal increase of vegal tone
5-Normalization of of the Bp
—Uses :
1- chronic HF> digoxin
2- Acute HF > Strophanthin K
3-Arterial fibrillation
—Contraindications
1-sever bradycardia
2-AV block
3-CNS: fatigue ,insomnia , change in the color of vision
4-GIT : Anorexia , Vomating, nausea
5- decrease Duress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

explain the Phosphodieastrase inhibitor drugs in HF ( Bipyradins )

A

-Drug : Milrinone Amp
-mechanism: they inhibit PDE enzyme type 3 which lead to increase cAMP and cAMp leads to Increase Calcium influx in myocardial cells which results of increase the strength of Contraction
—Adverse effect :
1-Thrombocytopenia
2-increase liver toxicity
-uses :
1-they are used IV only for short term treatment of CHF for patient who digoxin doesn’t affect on them
2-For acute AHF ( Acute Atrium Failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the Calcium Sensitizer Drug For HF

A

-Drug : Levosimendan Falcon 0,25%-5ml
-mechanism:
1-increase the sensitivity of Cardiomyocytes to Calcium by increasing myofilment Calcium by binding to Cardiac troponin in the calcium dependent manner
2- also its selective of Phosphodiestrase enzyme type 3 inhibitor which lead to Accumulation of cAMP which lead to
1-improve contractility
2-and vascular smooth muscle relaxation
—pharmacological effect :
1-V.D
2- decrease pre load and after load
3-Arrhythmoginc effect
-uses :
1-Acute HF
2-Acute decomposition CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the Df , AP of Cardiac and its Phases , differences between Phase 4 in Atrium and ventricular, pathophysiology of Arrhythmia

A

-DF of AP : in the resting state K+ ions is found mainly intracellular while Na+ and Ca+ extracellular making the intracellular is negative
-phases :
Phase 0 : rapid depolarization of the cells duo to rapid influx of Na+
Phase 1 : short period of Redepolazation duo to slow influx of K+
Phase 2 : Plateu delay in repolarization duo to slow influx of Ca
Phase 3 : second period of Rapid repolarization duo to rapid out influx of K+
Phase 4 : the resting state is restored , Na is extracellular , K+ back to intracellular by Na/K+ pump
- Difference between Phase 4 in Atrium and ventricular : is the slop the atrium consist of Slop duo to pre entering of Ca+ to the cells in this phase
—Pathophysiology of Arrhythmia:
-Df : its disturbance in the normal heart rhythm and its results from :
1-Abnormal impulse generation
2-abnormal impulse conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classification of Arrhythmia, and its drugs

A
  • Classification of arrhythmia:
    1-Bradyarrhythmia AV block : drugs > Atropin , Adrenaline , isoprenaline
    2-tackyarrhythmia : consist of 4 classes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain Class 1A/1B/1C in arrhythmia

A

1A class
—its increase the APD by inhibition of Na channel
-Drugs :
1-Quinidine tab
2-Disopyramide tab
3-Procainamide tab
—mechanism:
1-they block Na+ channel leading to decrease the Rate of Phase 0 depolarization which lead to increase The APD
2-decrease the exitibality on the atrial side slop which lead to decrease the firing of SA nodes
—pharmacological effect :
1- Arropine like action duo to blocked of muscranic receptor
2-hypotension duo to block of à receptor
Automatism↓
Excitability ↓
Conductivity ↓
Contractility ↓
-side effect :
1-Atropin like action
2-hypotension
3-small doses cause increase AV conduction
4-negative Iontropic effect
- uses :
1-Supraventrecular Arrhythmia
2-ventricular tachyarrhytmia
—NB : the difference between Procainamide and Quinidine is that Procainamide cause SLE like
——————————————————————
-1B class
—they are decrease the APD
-drugs :
1-Lidocaine Amp ,
2-Mexiletine Caps
3-Phenytoin tabs
—mechanism: it decrease the APD by increasing K+ in the 3rd phase ( repolarization) which llead to decreas APD
–pharmalogical effect :
Automatism↓
Excitability ↓
Conductivity ↓
Contractility ↓
—uses :
1-ventricular tachyarrhythmia
2-Acute MI > lidocaine
3-Arrhythmia with over dose of cardiac glycosides > phenytoin
—————————————————————-
Class 1C
—they have no effect of the APD
-Drugs : Propafenone amp ,Ethacyzin tab
-mechanism: by slowing the influx of sodium ions into the cardiac muscles cells causing decrease in :
Automatism↓
Excitability ↓
Conductivity ↓
Contractility ↓
-uses :
1-Supraventrecular
2-ventricular Arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

explain class 2 in arrhythmia

A

— class 2 are B.Blockers
-Drugs :
1-selective : B1> metoprolol ,Atenolol
2-nonselective : Propranolol tabl
-mechanism: they block Sodium, Potassium, Calcium , channel’s which lead to inhibition of phase 4 and depress Autmoticity and prolong Av conduction , alsodecrease HR , :
Automatism↓
Excitability ↓
Conductivity ↓
Contractility ↓
—Side effect :
1-CVS : decrease conductivity, bradycardia , AV block , hypotension
2-Respiratory: bronchispasm
3-GiT : dyspipsia
4- CNS : inly lipophlic drug such as Atenolol > depression
-Uses :
1-Supraventrecular
2-And ventrecular tachyarrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain Class 3 in arrhythmia

A

—They are K+ channel blocker
-Drugs :
1- Amiodarone Tab / Amp
2-Sotalol
-mechanism: inhibition of K+ channel in phase 3 which prolongate The Apd also inhibit Na+ and Ca+ , also casue Cornary V.D
-side effect :
1-Bradycardia
2-Arterial hypotension
4-Pulmonary fibrosis
5- photo sensitivity
6-hyperthyroidism
-uses : most type of arrhythmia
-contraindication: Arrhythmia duo to thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain Class 4 in arrhythmia

A

-They are clacium channel blocker
-Drugs :
1-Verapamil
2-diltiazem
-mechanism:its prolongate the APD through inhibation of Ca+ in phase 2 pleatue ,:
Conductivity ↓
Contractility ↓
Excitability ↓
Automatism:
atria ↓
—Side effect :
1- Decrease conductivity
2-bradycardia
—uses : superventercular tachyarrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain Cardiac Angaina , DF, Pathophysiology , Pathogenesis

A

—DF: impaired blood flow through the coronary Artery duo to :
1-Organic Athresclerosis
2-Thrombosis
—Pathophysiology:
-Types of IHD
1-Chronic Stable angaina
1.1 its duo to atherosclerosis and narrowing of the major branch of the heart
1.2 pain induce by effort
2-Acute Coronary Syndrome:
2.1 unstable Angina: its duo to rupture of the plaque
2.2 MI : its next stage of which above and charectrazed by complete occludes of the Epicardial Coronary Artery
3-Prenzmetal Angina ( vasospasmtic ) : its duo to a receptor overactivity , and its happen even in rest
—Pathogenesis:
- its imbalance between oxygen demand and supply of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain Antianginal drugs Classification

A

1-Nitrates / Nitrates like agent
2-B adrenergic Blockers
3-Calcium channel blocker
4-Other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain Organic nitrates , Classification, Pharmacokinetics ,Mechanism , Additional effect ,Side effect , Uses , Contraindications

A

—Drugs :
1-Nitroglycerin
2-Isosorbide Dinitrate
3-Isosorbide Mononitrate
4-Molsidomine
— Classification:
1-Short acting
1.1 Nitroglycerin ( Suplingual )
1.2 Isosorbide Dinitrate (Suplingual)
2- Nitrate like Agent: Molsidomine
3-Intermediate Act
3.1 Isosorbide dinitrate ( tab)
4-long acting
4.1 Isosorbide Mononitrate
—Pharmacokinetics:
-Absorption: good
-FPM: 90% While Mononitrate have no FPM
—Mechanism of Action :
-Nitrate release nitrate Oxide (NO) by the effect of Enzyme called Mitacondrial Aldahyed dehydrogenase 2 , NO stimulate Soluble Guanyly Cyclase and cause increase of the second massenger cGMP which is results of Smooth muscles relaxation by stimulating dephosphorlation of myosin light-chain phosphate which lead to :
1-Arterial dilation > decrease Pulmonary vascular resistance which is decreasing post load = decrease myocardial demand of O2
2-venous dilation > decrease venous return > decrease endosystolic volume > decrease pre load = decrease myocardial O2 demand
3-when Endosystolic decrease leads to decrease ventricular wall tension which lead to increase Sub endocardial blood flow = increase myocardial oxygen supply
4-Coronary vessels dilation > increase myocardial oxygen supply
—Additional effect :
1-relaxation of most smooth muscle ~ git , bronchi
2-decrease aggregations
—Side effect :
1-reflex tachycardia
2-Postural hypotension
3-Fascial flushing > duo to venous dilation
4-headache and dizziness
5-Tolerance
—Uses :
1-Acute HF > Nitroglycerin, Isosorbide dinitrate suplingul
2-IHD > isosorbide mononitrate
3-Acute Coronary syndrome , MI > IV nitroglycerin
—Contraindications:
1- mixed it with drug of PhospateDieastrase type 5 such as Sildenefi its potent the action id nitrate , and cause postural hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain B adrenergic blocker in Angaina , Drugs , mechanism,side effect , uses , Contraindications

A

—Drugs :
1-Propranolol > lipophilic , 1st gen , no selective
2-Bisoprolol > 2gen , selective B1
3-Metoprolol > lipophilic ,2gen , selective B1
—mechanism of action : They block B adrenergic receptor and decrease
cAMP which lead to decrease Ca result in effect on the heart and kidney which lead to :
1-decrease HR
2-decrease contractility
3-Decrease Renin
—side effect :
1-headache drawnness
2-bradycardia , AV block
3-hypotension
—Uses :
1-chronic classic angina
—Contraindications:
1-Vasospastic angina ( Premzemtal )
2-AV block
3-AHF
3-Bronchial asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain Calcium channel blocker , Drugs , mechanism, pharmacological effect , side effect , uses

A

—Drugs :
1-Verapamil 1gen
2-Diltiazem 1gen
3-Amlodipine 3 gen
—mechanism:
-They Block potential-dependent L-Type of calcium channel which decrease transmembrane Ca2+ current to heart and arteries which lead to :
1-Decrease myocardial oxygen demand duo to :
1.1 decrease HR ( verapamil )
1.2 decrease Post load
2-increase myocardial oxygen supply duo to :
2.1 Coronary dilation
2.2 increase subendoccardial blood flow
—Phramalogical effect :
1-Antihypertinsive
2-Antiarrhytmic
3-decrease Platelets aggregations
—Side effect :
1-CVS : bradycardia, AV block , reflex tachycardia
2-GIT : dyspepsia
3-CNS: headache
4-Allergic reaction
—uses :
1-Stable angina
2-Vasospastic Angina
3-hypertension
4-tachyarrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the newer drugs , Pfox inhibitor, Ivabradine

A

1-Pfox inhibitor
-Drug:
1-Trimetazidine tab
2-Ranolazine tab
-mechanism: inhibit fatty acid oxidation in the myocardial which lead to metabolic switch from fat to carbohydrates which is making the heart require less oxygen demand , also by inhibition of fatty acid oxidation they decrease intercellular lactic acidosis leading to decrease intercellular calcium , Sodium accumulation and ion disturbance , and prevent cell necrosis
——
-newer drug
-Ivaberdini tab 0,005
-mechanism: its heart rate lowering drug agent that act by selectively inhibit the cardiac peacemaker (If ) mixed sodium potassium channel which lead to bradycardia
-side effects: sever bradycardia
-uses : Chronic Classic Angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

explain the lipoprotein metabolism ( just for reading )

A

—it consist of 4 phases
1—1st Phase in the intestine: the diatry fats which is cholesterol and triglycerides comes to intestine and in order to get absorbed:
1- need to become fatty acid again by help of pancreatic lipase
2-and then get coverd by bile acid which is synthesized from cholesterol then its enter the enterocytes which its covered again and thorough out to blood stream in shape of chylomicrons
2—Phase 2 in blood : the chylomicrons in the blood get metabolism by enzyme found in the walls of the arteries called lipoprotein lipase its only metabolis the triglycerides in the chylomicrons till its reach the liver As chylomicrons Remanent
3—Phase 3 in the liver : in the liver the source of lipids are 3 :
1-Chylomicrons remanent = cholesterol
2-Synthesis of cholesterol by endogenous by Cholesterol precursors and with help of HMG-CoA reducase enzyme to form Cholesterol
3-Adipose tissue : release triglycerides by lipolysis and its reach the liver
— the liver combined all these lipids together and through them in the blood stream in shape of VLDL
4–Phase 4 in blood stream: in the blood stream we have VLDL and also there is lipoprotein lipase so the VLDL get metabolic > IDL> LDL the LDL then get to liver and bind to receptor called LDL receptor then the liver make these lipids into hormons , bile acid , ETC
-NB! in case of genetical problems and the body doesn’t have LDL the LDL remain in the blood and gets into the endothelial layer of the Arteries and with calcium form sold substance which is lead to Athreoscelerosis
- some time the body break this sold substance and resend it to the liver in the shape of HDL in this case is good because the body is correcting the huge amount of lipid. and the LDL doesn’t need receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain DF of Hyperlipidima , Classification

A

—Df : its abnormal elevated levels of any or all lipids in the blood
-Normal levels
1-Tottal Cholesterol: < 240/dl
2-Tottal triglycerides:< 150/dl
—Classification:
-genetic :
-type 1 : increase chylomicrons : chylomicronimia
-types 2:
-A : increase LDL : hypercholystronemia
-B : increase LDL + VLDL : combined hyperlipidnima
-type 3 : increase IDL : Dysbetalipoprotinima
-type 4 : increase VLDL : hypertruglycerdnimia
-type 5 : increase VLDL + cholesterol: mixed triglycerdnima
—Aqauierd : DM , RF alcohol , Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain HGM-CoA recutase enzyme inhibitor drugs , mechanism, side effect , uses , drug interactions

A

—Drugs :
1-Atorvastatin tab
2-Rosuvastatin Tab
—mechanism:
they are competitive inhibitor for HGM-CoA enzyme inhibitor which lead to decrease cholesterol synthesis in the liver and increase uptake of LDL
-side effect :
1-hepatic dysfunction : reversible
2-myopathy,myositis
3-GIT upset
4-Cataracts in the eye
-Uses :
1-hypercholystronemia
—Drug interaction :
1-CYP450 inhibitor , which may induce the myopathy and myositis
2- also combined with Fibrates

21
Q

explain The PCSK9 inhibitor drug , mechanism, side effect , uses

A

—Drug : Alirocumab Amp S.c
—Alirocumab its monoclonal antibody for PCSK9
-mechanism: PCSK9 its protein synthesis by many tissue in the body including the liver and its promotes lysosomal degeneration of LDL receptor in the liver , So inhibiting of this receptor lead to increase LDL receptors
—Side effect : flu like symptoms
-Uses : hypercholestrolenima

22
Q

explain Fibrates , Drugs , mechanism, side effect , uses

A

—Drug : Fenofibrate tab
-mechanism: its act on nuclear receptor called PPAR-a proxisome proliferator activated receptor Alpha leading to increase synthesis of lipoprotein lipase which lead to increase catabolism of VLDL and chylomicrons
—Side effect :
1-GIT upset
2-increase formation of Gall stones
3-reversible hepatic dysfunction
4-myopathy
—Uses :
1-hypertriglyceridnemia
2-Combined hyperlipidnima
3-dysbetalipoprotenima
4-mixed hypertriglycerdenima

23
Q

explain the Nicotinic Acid , Drugs , mechanism, side effect ,uses

A

—Nicotinic Acid tab SR NB! its Vitamin B3
-mechanism: Niacin inhibit lipolysis of triglycerides from the adipose tissue
which is lead to decrease the catty acids that reach. the liver results of decrease synthesis of LDL and VLDL
-side effect :
1- skin flushing and burning sensations
2-hyperglycemia
4-GIT upset
-uses :
1-Hypercholstrolenima
2-hypertriglycerdneima
3-Combined hyperlipidenima

24
Q

Explain the Cholesterol Absorption inhibitor drugs , mechanism, side effect , uses ,

A

—Drug : Ezetimibe tab
-mechanism: its selective inhibitor of cholesterol absorption and its effect even in absent of diatry fat becs its inhibit Reabsorption of cholesterol that excreted in the bile
-uses : hypercholstrenemia

25
Q

explain the Bile acid sequestrants drugs , mechanism, side effect

A

-Drug : Cholystyramine tab
-mechanism: its bind to bile acid in the intestine and decrease absorption of cholesterol and decrease cholesterol storage in the body
-Side effect :
1-GiT upest
2-Decrease Absorption of the Fat sulobale drugs or Vitamins
—uses :
1-Hypercholestronima

26
Q

Explain The molecular mechanism of Hypertension , Ca increase sites , mechanism of increasing Ca+

A

-in vascular smooth muscles the Ions
K+,mg is mainly intercellular and the Na,Ca is mainly extracellular, in the case of Na/Ca channels opens they enters tge cells and cause depolarization, and Mg/K+ channel opens and they get extracellular, in case of hypertension the mechanism is that Ca open and it enters the cell and UNITE with protein called Clumodulin then this protein will phosphorylate enzyme called myocine kinase light-chain and then actin and myocin fliment unite to each other and causes V.C and
—Ca increase sites :
1-channels opens
2-binding sites
3-Sarcoplasmic reticulum
—mechanism of increase Ca+
1-a1 activate Gq > ip3 ( inositol triphosphat 3 ) > increase Ca > Vc
2-ADH ( Vasopressin) > Activate V1 > ip3 > Ca increase > V.C
3-Ang 2 > Activate > AT1 > ip3 > Increase Ca > VC
4-Enothlein > Activate ET1 > ip3 > increase Ca > VC

27
Q

Classification of hypertension drugs

A

-First line drugs :
1-B.B
2-CCB
3-ACEI
4-ARA
-2nd line :
1-Alpha 1 blocker
2-a+B blockers
3-Adrenergic neruon blocker > methyldopa
4- Vasodilators

28
Q

Explain B.Blockers in Hypertension , Drugs , mechanism, uses , Contraindications

A

-Drugs :
1-propranolol : non selective, lipophilic
2-metoprolol: B1 , lipophilic
3-Atenolol : B1 hydrophilic
4-Bisoprolol : B1
5-Nebivolol : B1 ,No production
6-Carvedilol : a+B blacker , No production
—mechanism: by inhibition of B receptor its lead to , decrease Cop, decrease renin release , blocking b2 in nerve ending lead to decrease NA release , resting of baroreceptor in cardiac which lead to bradycardia , also they have Vasodilation action which increases synthesis of ,PG , NO , also inhibit a1, this effect only happens with 3rd generation only
—uses :
1-hypertension with cardiac problems such as , IHD,HR,Arrhythmia
2-hypertension with pheochromocytoma = Carvedilol
3-young age with hypertension bcs mean that its from stress thats mean renin and B1 can block it
— Contraindications: obstructive pulmonary disease
-NB!its better to use B1 selective unless its the case required specific treatment

29
Q

Explain CCB , Drug groups , mechanism of action , pharmacological effect , side effect , uses , Contraindications,

A

—Drug groups :
1-Dihydroperiden : Nifedipine,Amlodipine , nicardipine> vascular selective
2-Benzodiazepines: Diltiazem
3-phinylalklamine : Verapamil > Cardio Selective
—mechanism:
1-it decrease peripheral vascular resistance by blocking of potential-dependent L type Ca+ channel which lead to decrease Ca+ in smooth muscles of arteries and result of decreasing vascular tone
2-its also decrease heart rate and Cop negative ion-tropic and chronotropic effect in case of use Verapamil , Diltiazem
—Pharmacological effect :
1-Smoothie muscles relaxtion
2-Cell necrosis: decrease cell necrosis bcs Ca+ is essential for apoptosis
3-decrease insulin release
4-decrease nuronal firing bcs Ca+ is essintial
5-Platelets: decrease platelets aggression because Ca+ is essential
—Side effect :
1- Bradycardia ; verapamil , Diltiazem
2- Reflex tachy : Nifedipine
3-hypotension
4-Constapiation : duo to RAAS reflex
—Uses :
-Verapamil
1-IHD
2-SVT
3-hypertrophic obstractive cardiomyopathy
-Amlodipine
4-ischemic renal failure
5-hypertension im pregnancy : nifedipine
—Contraindications:
1-CHF
2-bradycardia, AV block
3-in combination with digoxin or B.B because all of them nogative iontropic
4-Wolf parkinson syndrome: which the patient have accessory bundle of kent

30
Q

Explain ACEi , drug groups , mechanism of Renal hypertension (RAAS) ,mechanism of action, receptors of Ang 2 , pharmacological effect , side effect , uses , Contraindications

A

—Drug groups :
1-Sulfhydrnal group : Captopril
2-non SH group : Enalapirl,Enalaprilate
—mechanism of Renal hypertension:
-when renal ischemia occurs and RBF , GFR decreased this lead to Acute oliguria that may develop acute tubular necrosis
- As comoplasatory mechanism , renin is released from jaxtaglumular cells as rescue message to stimulate RAAS as its follows :
-Renin > Angitensigen > Angiotensin’s 1 > ACE / kinins > ACE convert Angiotensin to Angiotensin 2 , And kinins metabolis bradykinies .
-Explanation : renin which released from the kidney goes to Angiotisgen which is inactive form and activating it which lead to Angiotensin 1 and with enzyme ACE converted to be Angiotensin 2 , also with ACE there is Another Enzyme called kinins which metabolise bradykinase which is responsible for VD
-Ang 2 : Acts on 2 receptors
1-AT1 : -its cause V.C and thus mentaine Adequate GFR , in another vascular tissue Ang2 act on AT1 casuing systemic V.C , cell hypertrophy, Increase Apoptosis
2-AT2 : V.D
—Mechanism of ACEI : by inhibition of ACE and kinase the affect will be :
1-decrease conversion of Ang1 to Ang2 = decrease vascular tone
2-decrease Aldesteron > decrease Na/water retention = increase K+
3-increase Bradykinin > increase synthesis of PG > decrease vascular tone
—Receptors of Ang2 :
1–AT1 : activating of AT1 : located mostly in efferent and its G-Protein linked receptor when its activated cause V.C duo to :
1-increase intraglumular hydrostatic pressure = Increase GFR
2-Systemic V.C
3-increase Aldesteron release = salt and water retention
4-Increase Vasopressin > V.C
5-increase proapoptotic protein which is lead to Increase apoptosis , so inhibtaion of this enzyme lead to decrease apoptosis and thats useful in IHD
2— AT2 : V.D
—Pharmacological effect :
-CVS :
1-hypotension without reflex tachycardia : duo to resting of baroreceptor
2-direct V.D action in artery and veins which lead to decrease pre/after load
3-increase Cop ( in patient with CHF)
4-decrease cardiac remodeling: duo to decrease apoptosis, and decrease hypertrophy
-side effect :
1-Cough : duo to accumulation of bradykinin
2-Angioedema :
3-protenuria
4-test changes
5-postural hypotension
6-pregnancy tetrognsis
7-skin rush: duo to sh group
8-hyperkalemia
—uses :
1-hypertension duo to RAAS
2-systemic hypertension
3-CHF : bcs its decrease pre/after load , and increase Cop and decrease Cardiac remodelling
4-late stage of MI
—Contraindications:
1-hypotension
2-Severe RF or renal artery stanosis
3-pregnancy : duo to fetal tetroginisis
4-hyperkemia
5-neutrophilina , thrombocytopenia: duo to bonemarrow depression
6-immunological problems

31
Q

explain ARA , Drugs , mechanism, side effects , Contraindications

A

—Drugs :
1-Losartan
2-Valsartan
-mechanism: they are selectively antagonist of Ang2 receptor AT1 which lead to :
1-decrease vascular tone
2-decrease aldesteron release = salt and water retention
3-increase renin > angiotensin 2 > AT2 lead to VD
4-have no effect of metabolism of Bradykinin
-Side effect :
1-hypotension
2-hyperkalima
3-hypatotoxcity
-uses :
1-hypertension in patient who used ACEI and casue cough or Angioedema
-Contraindications:
1-renal artery stenosis
2-pregnancy

32
Q

explain sodium nitroprusside , mechanism , side effect, use’s

A

-Drug: Sodium nitroprusside Amp
-mechanism: it consist of nitric oxide which increases cGMP which result of dilation of both veins and arteries and decrease pre/after load
-side effect :
1- it consist of cyanid so it can convert to toxic form and accumulation could casue toxicity more often happens with RF,LF and its antidot its Sodium thiosulfate
-uses :
-hypertension crisis

33
Q

explain the drug that most used in pregnancy hypertension, mechanism

A

-Drug : methyldopa Tab
-mechanism: alpha methyldopa convert to methyl norepinephrine centrally to decrease the adrenergic out flow of alpha 2 agonist action from CNS leading to decrease total peripheral resistance and systemic Bp
-uses : hypertension in pregnancy

34
Q

Explain Centrally acting Antihypertensive drug , mechanism, side effect , uses

A

-drug : Clonidine Amp
-mechanism: its stimulating the presynaptic a2 adrenoreceptor which lead to decrease noradrenaline reales from both central and peripheral sympathetic nerve terminal
-side effect
1-sedation
2-postural hypotension
3-Constipation
-uses : hypertension crisis

35
Q

explain the classification of diuretics

A

1-loop durtics
2-thiazides
3-potassium sparing
4-Carbonic anhydrase inhibitors (CAI)

36
Q

explain loop diuretics, drugs , mechanism,pharmacological effect , side effect, uses

A

—Drugs :
1-Furosemide amp/tab
2-torasemide amp / tab
3-Ethacrynic acid tab
-mechanism: the location of action is in the ascending loop of henle and they block the transports channel Na/K+/Cl- , also increasing synthesis of PGE1,I2 and improve blood supply of kidney which is lead to excrete :
1-Na/water
2-K+/cl-
3-Ca/mg
4- H+
—pharmacological effect
1-powerful duirsis accompind with loos of K+/Ca/mg
2-Vasodilation
3-increase blood supply of kidney duo to increase synthesis of PgE2,I2
4-VD of pulmonary duo to formation of PG increase
-Side effect:
1-hypovolmia
2-hypotension
3-metabolic alkalosis : duo to loss of H+
4-hyperurecimia : duo to increase uric acid reabsorption in PCT as result of hypovilemia
5-ototoxicty : reversible hearing loss duo to disturbance of ion transportation in inner ear , mostly occurs in high doses
6-allergic reaction : dou to SH group except Ethacryinc acid
-uses :
—Chronic :
1-CHF
2-Liver Cirrhosis
3-RF
—emergency:
1-Pulmonary edema , Cardiac Asthma
2-Acute glucoma attack
3-posinig with water sulable toxins
4-hypertensive crisis : Furosemide IV duo to :
-decrease plasma volume
-decrease vascular smooth muscles
-peripheral VD

37
Q

explain thiazides , Drugs , mechanism, pharmacological effect, side effect , uses

A

-Drugs :
1-hydrochlorothiazide
2-Clopamide
2-indapamide all tabs
—mechanism: the location of action is the Proximal part of DCT they block
Na/Cl- transport channel and increase Ca reabsorption , and inhibit Carbonic anhydrase enzyme in the PCT , also decrease Na input in smoothie muscles sensitivity to VC
-pharmacological effect :
1-moderate dursis
2-VD
3-decrease production of interocular fluid
4-decrease loos of Ca+
—side effects:
1-hypokalmia
2-hypomagnsimia
3-hyperurecimia ( duo to competition with urates ) ( its ++ uric acid in urine )
4-hyperclacimia
5-hyperglycemia
6-metabolic alkalosis
7-hypotension
—uses :
1-hypertension ( long term treatment )
2-Chronic peripheral edema in :
CHF , liver cirrhosis, miled RF
3-idiopathic hyperclaciuria

38
Q

explain K+ sparing , Drugs , mechanism, side effect , use’s,

A

—Drugs :
1-Spironolactone
2-Amiloride
3-Triamterene
—mechanism: drugs have different mechanism :
1-Spironolactone : its comparative antagonist of aldesteron-dependent-sodium-potassium receptor at the distal site of DCT leading to increase Na/water execration and K+ retention
2-Amiloride/Triamterene : they block the entery of Na/H2o At the distal part of DCT and collecting duct which lead to increase Na/water excration and K+ retention
-side effect :
1-hyperkalamia
2-Acidosis: duo to H+ retention
3-gyncomastia
4-menstrual irregularities
5-erectail dysfunction
-uses of spironolactone:
1-primary hyperaldestornsim ( Cohin syndrome )
2-Secondary hyperaldesttonsim
3-CHF
4-Hypertension
5-hypokalimia

39
Q

explain Carbonic anhydrase inhibitor, drugs , mechanism, pharmacological effect , uses , Contraindications

A

-drugs :
1-Acetazolamide tab
2-Brinzolamide eye drops
—mechanism: inhibition CAI lead to decrease H+ formation inside the cell , decrease Na/H+ anti-port, increase Na+ and HCO3 in lumen which is lead to increase duress
—mechanism in the eye : its decrease the formation of Aqusomer fluid in the Eye which is lead to decrease IOP
—pharmacological effect:
1-mild duress
2-sever acidosis
3-decrease ICF
4-Decrease IOF
—uses :
1- no druess use anymore duo to acidosis
2-glucoma
3-intercernial hypertension
4-as adjuvant drug for epilepsy
-Contraindications:
1-Liver cirrhosis duo to decrease execration of ammonia which lead to hepatotoxicity

40
Q

explain Anticoagulant,Df ,Classification of Anticoagulant

A

—Df: Anticoagulant medication thats help to prevent blood clots formation
—Classification:
1-Directly acting
1.1 Heparin
1.2 low molecular heparin ( dalteparin,Enoxaparin)
1.3 syntactic pentasaccraid : Fondaparinux
2-directly acting factor inhibitor:
2.1 Rivaroxaban ( inhibit factor 10)
2.2 Dabigatran ( inhibit factor 2 )
3-Indirectly acting :
3.1 Warfarin tab

41
Q

explain Heparin , Pharmacokinetics, mechanism, pharmacological effect , adverse effect , Uses ,

A

—Drug:Heparin S.c / IV
-Pharmacokinetics:
1.1 Absorption: no because breakdown by HCL
1.2 distributable: dosnt pass BBB/Placenta
—mechanism: its action depends on the presence of Natural cloting inhibitor called ( heparin cofactor : Antithrombine 3) in the plasma small amount of heparin cofactor can activate Antithrombine 3 which lead to inhibition of several clothing factor especially factor 10 and 2
-pharmacological effect :
1- Anticougulant in vivo and vitro
2- Stimulate lipoproteins which decrease TGs in serum
—Adverse effect :
1-bleeding the most common side effect : Anti dot its Protamine sulfate
2-hematoma
3-osteoprosis : prolonged use of heparin inhibit proteins that stimulate osteoblast
—uses :
1-treatment of established thrombosis : to decrease its expand
2-prevention of thrombosis
—Contraindication:
1-MI

42
Q

Explain Low molecular wight heparin

A

—Drugs :
1-Enoxaparin Amp s.c
2-Dalteparin Amp s.c
—mechanism: same mechanism of heparin but more specific on Anti factor 10

43
Q

explain Anticoagulant Direct Acting on factors

A

1-Factor 10 inhibitor
1.1 Drug : Fondaparinux amp
- synthetic polysaccharides that has the same mechanism of lwmh selective inhibitor of Factor 10 and long acting
1.2 Drug : Rivaroxaban Tab
-Selective factor 10 inhibitor has. the same mechanism of LwMH
2- Direct Inhibitor of Factor 2 ( thrombin)
-drug: Dabigatran Tab
-synthetic compound thats acts as thrombin inhibitor, its can be used as alternative to heparin to treat patient with heparin-indenednt thrombocytopenia

44
Q

Explain the Anticoagulant Warfarin, Pharmacokinetics,mechanism ,pharmacological effect , adverse effect , uses

A

—Drug : Warfarin tab
-pharmacokinetics:
1-Absorption: good bioavailability
2-distribution : Can cross BBB
—mechanism: Warfarin inhibit Vit K epoxied reeducates enzyme in the liver leading to inhibition of formation of the active form of Vit K which is lead to decrease synthesis of Vit k-dependent cloting factor ( 2,7,9,10) which is lead to inhibation of carboxlase resulting in decrease modification of factors
—pharmacological effect :
1-Anticougulant in vivo
2- long acting 3-7 days
—Adverse effect :
1-bleeding of major organs : can be antagonis by Vit K
—uses :
1- treatment and prevention of : DVT,post operative thrombosis , Cerebral veouns thrombosis

45
Q

explain Warfarin Polymorphism

A

—–Variation in dose requirements is different for everyone, and genetic factors have an effect on dose variation. Polymorphism of vitamin K epoxide reductase complex 1 (VKORC1) gene is identified as the main genetic factor involved in warfarin dosage requirement variations.
–CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.

46
Q

Explain Antiplatlet drugs

A

—Classification:
1-NSAIDS
2-grel
3-phosphodiestreas inhibitor
4-Monoclonal Antibody
——
1-NSAIDs
—Drug : Acetylsalisalic Acid Tab
-mechanism: its inhibt Cox irrivarsbaly witch lead to decrease THA2 which is responsible for platelet agg
-Pharmacological effect :
1-in low dose : anti agg
2-in high dose : analgasic and antypyratic , anti inflammatory
—side effect :
1-Git ulceration
2-risk of bleeding
3-bronchospasm
—uses :
1-prophylaxis of thrombosis’s
2-to reduce MI recurrent
—————————-
2-Grel
-Drugs :
1-Clopidogrel Tab
2-Prasugrel
3-Ticagrelor
—mechanism: they bind to receptor in the platelets called P2Y12 in site of the chemical mediator ADP should bind to start the aggression , so they bind to this receptor and inhibit ADP from binding and activate of GP2b/3a which is required for platelets to bind to fibrinogen and each other
—Pharmacokinetics:
1-Ticagerlor : 1-3 h and bind irreversibly
2-prasugrel : 2-4 h bind reversible
3-Clopidogrel : 3-5 days bind reversible
—metabolism: they metabolic by CYP450
-Clopidogrel : this drug is pro drug witch mean is that need to metablose to be active , So clopidogrel is metabolize By CYP2C19 , People with polymorphism of this gene lead to reduce clinical responseof Clopidogrel ,
-Drug such as Omeprazole is inhibit the CYP2C19 which is lead to drug drug interaction
—Side effect : bleeding
-uses : prophylaxis of thrombosis
—————————————————

46
Q

Explain Antiplatlet drugs

A

—Classification:
1-NSAIDS
2-grel
3-phosphodiestreas inhibitor
4-Monoclonal Antibody
——
1-NSAIDs
—Drug : Acetylsalisalic Acid Tab
-mechanism: its inhibt Cox irrivarsbaly witch lead to decrease THA2 which is responsible for platelet agg
-Pharmacological effect :
1-in low dose : anti agg
2-in high dose : analgasic and antypyratic , anti inflammatory
—side effect :
1-Git ulceration
2-risk of bleeding
3-bronchospasm
—uses :
1-prophylaxis of thrombosis’s
2-to reduce MI recurrent
—————————-
2-Grel
-Drugs :
1-Clopidogrel Tab
2-Prasugrel
3-Ticagrelor
—mechanism: they bind to receptor in the platelets called P2Y12 in site of the chemical mediator ADP should bind to start the aggression , so they bind to this receptor and inhibit ADP from binding and activate of GP2b/3a which is required for platelets to bind to fibrinogen and each other
—Pharmacokinetics:
1-Ticagerlor : 1-3 h and bind irreversibly
2-prasugrel : 2-4 h bind reversible
3-Clopidogrel : 3-5 days bind reversible
—metabolism: they metabolic by CYP450
-Clopidogrel : this drug is pro drug witch mean is that need to metablose to be active , So clopidogrel is metabolize By CYP2C19 , People with polymorphism of this gene lead to reduce clinical responseof Clopidogrel ,
-Drug such as Omeprazole is inhibit the CYP2C19 which is lead to drug drug interaction
—Side effect : bleeding
-uses : prophylaxis of thrombosis
—————————————————
3-Phophodiestrase
-drug : Dipyridamole tab
-mechanism: they are phosphodiesterase inhibitor which is responsible for converting the cAMP to AMP which is important for increasing Ca2 and increase platelets agg
-Pharmacokinetics:
1-good bioavailability
2-high protein bounded
3-VD
-Side effect :
1-headech
2-hypotension especially in IV
-uses :
1-Protection of stroke with. companion of Aspirin
—Contraindications:
1-Unstabil angania duo to VD effect which can increase the ischemia
—————————
4/Monoclonal Antibody
-Drug : Abciximab Amo ivi
-mechanism: they are monoclonal antibody , binde to Gp3/2a and blocks the binding site which is responsible for fibronogen linking and agg will not occur
-pharmacokinetics:
inhibiton of platelets in 30min
-uses :
in combination with heparin and aspirin for percoutnes Cornary intervantion , and cardiac ischemic complications

47
Q

explained Thrombolytics , Drugs , mechanism, side effects , uses

A

—Drugs :
1-Urokinase iV , : its products from kidney
2-Streptokinase IV : its from streptococcal
3-Alteplase IV : tissue plasminogen activator or TPA
—explainion of the mechanism: normally when fiber clot is formed plasminogen get in contact with the clot and becomes activated into plasmin By the help do naturally occurring tissue called
( tissue Plasminogen activator T-PAs)
and plasmin causes fibrolysis
—mechanism:these drugs cause Rapid activation of T-PAs to form plasmin , and cause fibrolysis
-side effect :
1-systemic bleeding
2-allergic reaction , fever , hypotension ( streptokinase)
—uses : Acute MI

48
Q

explain the Fibrolysis inhibitor

A

—Drugs :
1-Tranexamic acid tab / Amp
2-Aminocaproic Acid Amp
—mechanism: they inhibit both activation of Plasminogen and plasmin by binding to lysin-binding site within the plasminogen/plasmin molecular which inhibit the plasmin to lysis the fibren clot
—side effect :
1-Vascular thrombosis
—uses : internal bleeding